Yamada et al. evaluated the effectiveness of LDLT clarithromycin in patients with non-allergic CRSwNP and found a significant reduction in nasal polyp size and IL-8 secretion in 40% (8 of 20) of patients [81]. The gene discussed is CXCL8; the disease is nasal cavity polyp.